months of diabetes duration
short duration of diabetes
different diabetes duration
vascular complication of diabetes
early diabetes
study of patrollers
role of  patrollers
number of circulating patrollers
biosynthetic profile of patrollers changes
retinal vascular damage
evolving vascular damage
healthy vessels
Patroller monocytes
retinal vessels
modulators of diabetic retinopathy
phase of vascular repair
T1DM patients
discrete subpopulation of circulating monocytes
clinical applicability
clinical investigation
human study
initial nonproliferative DR
healthy control subjects
healing
leading cause of legal blindness
relation
trophic factors
endogenous systems
adults
types of molecular actions
cells
protective transcriptional program
monocyte subset
functional characteristics
inflammatory cytokines
speed
Europe
leukostasis
long latency period
beneficial activities
crawling
years
efficacy
magnitude lower
natural history
preliminary data
variance
endothelium
expectation
project
time
Objectives
leverage